Dan Wieder

Managing Director
16 years industry experience

Biography

Dan is a Partner and Investment Committee member for the Morgan Stanley Secondaries team. He has 16 years of industry experience. Prior to his current role, Dan was the first analyst to join the Morgan Stanley Secondaries team at inception, focusing on due diligence of all secondary transactions. Dan received a B.S. with highest distinction in finance from the Pennsylvania State University.

Daniel is a member of the
Morgan Stanley Private Equity Secondaries Team

View Team

Strategies

Strategies

Strategy Name	Description
Private Equity Secondaries	Provides exposure to private equity fund interests acquired in the secondary markets.

Private Equity Secondaries

Provides exposure to private equity fund interests acquired in the secondary markets.

News & Insights

News & Insights

Morgan Stanley Private Equity Secondaries Completes Equity Financing Alongside RunTide Capital in ATSG and Evolve IP

Investment funds managed by Morgan Stanley Private Equity Secondaries, through a vehicle managed by RunTide Capital, announced today the completion of an equity financing between ATSG and Evolve IP.

Impilo Closes €320m Single Asset Continuation Fund Transaction to Support the Continued Growth of Immedica Pharma

On 20th September 2024, Impilo, a Nordic healthcare investment firm and KKR, a leading global investment firm, announced the completion of their joint acquisition of Immedica Pharma.

Impilo Closes €320m Single Asset Continuation Fund Transaction to Support the Continued Growth of Immedica Pharma

On 20th September 2024, Impilo, a Nordic healthcare investment firm and KKR, a leading global investment firm, announced the completion of their joint acquisition of Immedica Pharma.

View More Press Releases